The abnormal kinetics and levels of CD28 and CD152 expression on T cells in B-CLL may lead to a state of hyporesponsiveness or anergy and could be one of the mechanisms of immune deficiency in this disease. The gene discussed is CTLA4; the disease is B-cell chronic lymphocytic leukemia.